[{"Assets_0_Q3_USD":33977000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":1655000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":1645000000.0,"StockholdersEquityConverted_0_Q3_USD":14914000000.0,"StockholdersEquity_0_Q3_USD":14783000000.0,"RevenuesConverted_3_Q3_USD":14212000000.0,"RevenuesConverted_1_Q3_USD":4862000000.0,"NetIncomeLossConverted_3_Q3_USD":3335000000.0,"NetIncomeLossConverted_1_Q3_USD":845000000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":4158000000.0,"EarningsPerShareDiluted_3_Q3_USD":2.02,"EarningsPerShareDiluted_1_Q3_USD":0.51,"EarningsPerShareBasic_3_Q3_USD":2.02,"EarningsPerShareBasic_1_Q3_USD":0.52,"CommonStockDividendsPerShareDeclared_3_Q3_USD":1.17,"CommonStockDividendsPerShareDeclared_1_Q3_USD":0.39,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":1639000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":1648000000.0,"Ticker":"BMY","CIK":"14272","name":"BRISTOL MYERS SQUIBB CO","OfficialName":"Bristol-Myers Squibb Company Common Stock","form":"10-Q","period":"20170930","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"162365000000.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"SP500","filed":"20171026"}]